Insider Transactions in Q2 2021 at Avalo Therapeutics, Inc. (AVTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
H Jeffrey Wilkins Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
912
+3.27%
|
$1,824
$2.28 P/Share
|
|
Jun 10
2021
|
James Archie Harrell Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
7,493
+17.36%
|
$14,986
$2.28 P/Share
|
|
Jun 10
2021
|
Schond L. Greenway CFO |
BUY
Open market or private purchase
|
Direct |
652
+28.3%
|
$1,304
$2.68 P/Share
|
|
Jun 10
2021
|
Garry Arthur Neil CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,692
+4.34%
|
$7,384
$2.28 P/Share
|
|
May 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,000
+0.06%
|
$44,000
$2.33 P/Share
|
|
May 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,000
+0.08%
|
$60,000
$2.2 P/Share
|
|
May 14
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 14
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
128,000
+0.33%
|
$256,000
$2.15 P/Share
|
|
Apr 15
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
0
|
-
|
|
Apr 15
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
6,285,715
+13.9%
|
$12,571,430
$2.0 P/Share
|